annual EBITDA:
$4.27B+$480.00M(+12.67%)Summary
- As of today (August 18, 2025), CME annual EBITDA is $4.27 billion, with the most recent change of +$480.00 million (+12.67%) on December 31, 2024.
- During the last 3 years, CME annual EBITDA has risen by +$1.24 billion (+40.84%).
- CME annual EBITDA is now at all-time high.
Performance
CME EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$1.21B+$22.20M(+1.86%)Summary
- As of today (August 18, 2025), CME quarterly EBITDA is $1.21 billion, with the most recent change of +$22.20 million (+1.86%) on June 30, 2025.
- Over the past year, CME quarterly EBITDA has increased by +$127.90 million (+11.79%).
- CME quarterly EBITDA is now at all-time high.
Performance
CME quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$4.54B+$127.90M(+2.90%)Summary
- As of today (August 18, 2025), CME TTM EBITDA is $4.54 billion, with the most recent change of +$127.90 million (+2.90%) on June 30, 2025.
- Over the past year, CME TTM EBITDA has increased by +$554.10 million (+13.90%).
- CME TTM EBITDA is now at all-time high.
Performance
CME TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CME EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.7% | +11.8% | +13.9% |
| 3 y3 years | +40.8% | +44.4% | +40.8% |
| 5 y5 years | +38.9% | +61.5% | +36.9% |
CME EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.8% | at high | +59.8% | at high | +40.8% |
| 5 y | 5-year | at high | +40.8% | at high | +90.8% | at high | +59.2% |
| alltime | all time | at high | >+9999.0% | at high | +3548.5% | at high | >+9999.0% |
CME EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.21B(+1.9%) | $4.54B(+2.9%) |
| Mar 2025 | - | $1.19B(+15.5%) | $4.41B(+3.4%) |
| Dec 2024 | $4.27B(+12.7%) | $1.03B(-7.0%) | $4.27B(+1.9%) |
| Sep 2024 | - | $1.11B(+2.1%) | $4.19B(+5.0%) |
| Jun 2024 | - | $1.08B(+3.8%) | $3.99B(+4.1%) |
| Mar 2024 | - | $1.04B(+10.0%) | $3.83B(+1.1%) |
| Dec 2023 | $3.79B(+12.1%) | $949.50M(+4.5%) | $3.79B(+5.3%) |
| Sep 2023 | - | $908.50M(-2.1%) | $3.60B(+2.3%) |
| Jun 2023 | - | $927.90M(-7.4%) | $3.52B(+2.6%) |
| Mar 2023 | - | $1.00B(+32.1%) | $3.43B(+1.5%) |
| Dec 2022 | $3.38B(+11.5%) | $758.90M(-8.4%) | $3.38B(+1.0%) |
| Sep 2022 | - | $828.80M(-1.3%) | $3.35B(+3.7%) |
| Jun 2022 | - | $839.80M(-11.7%) | $3.23B(+2.2%) |
| Mar 2022 | - | $951.00M(+31.0%) | $3.16B(+4.2%) |
| Dec 2021 | $3.03B(-2.3%) | $726.20M(+2.3%) | $3.03B(+3.1%) |
| Sep 2021 | - | $709.90M(-7.9%) | $2.94B(+2.3%) |
| Jun 2021 | - | $771.20M(-6.3%) | $2.87B(+0.7%) |
| Mar 2021 | - | $823.30M(+29.6%) | $2.85B(-8.0%) |
| Dec 2020 | $3.10B(+0.9%) | $635.50M(-1.2%) | $3.10B(-1.7%) |
| Sep 2020 | - | $643.00M(-14.4%) | $3.16B(-4.9%) |
| Jun 2020 | - | $750.80M(-30.0%) | $3.32B(-2.1%) |
| Mar 2020 | - | $1.07B(+55.6%) | $3.39B(+10.7%) |
| Dec 2019 | $3.07B(+6.3%) | $689.20M(-14.5%) | $3.06B(-1.7%) |
| Sep 2019 | - | $806.40M(-1.8%) | $3.11B(+7.0%) |
| Jun 2019 | - | $821.00M(+10.3%) | $2.91B(+3.7%) |
| Mar 2019 | - | $744.60M(+0.3%) | $2.81B(-1.7%) |
| Dec 2018 | $2.89B(+14.9%) | $742.60M(+23.0%) | $2.86B(+5.7%) |
| Sep 2018 | - | $603.80M(-15.9%) | $2.70B(-0.5%) |
| Jun 2018 | - | $718.00M(-9.4%) | $2.72B(+2.3%) |
| Mar 2018 | - | $792.70M(+34.6%) | $2.66B(+2.0%) |
| Dec 2017 | $2.52B(+2.5%) | $588.90M(-4.8%) | $2.61B(+0.1%) |
| Sep 2017 | - | $618.60M(-6.0%) | $2.60B(+1.0%) |
| Jun 2017 | - | $658.00M(-11.2%) | $2.58B(+1.6%) |
| Mar 2017 | - | $741.10M(+26.7%) | $2.54B(+3.4%) |
| Dec 2016 | $2.46B(+11.3%) | $585.00M(-1.4%) | $2.45B(+2.6%) |
| Sep 2016 | - | $593.20M(-4.0%) | $2.39B(+0.9%) |
| Jun 2016 | - | $617.70M(-6.2%) | $2.37B(+2.5%) |
| Mar 2016 | - | $658.60M(+25.8%) | $2.31B(+4.3%) |
| Dec 2015 | $2.21B(+10.6%) | $523.50M(-8.4%) | $2.22B(+0.4%) |
| Sep 2015 | - | $571.50M(+2.2%) | $2.21B(+4.1%) |
| Jun 2015 | - | $559.30M(-0.5%) | $2.12B(+4.1%) |
| Mar 2015 | - | $562.30M(+9.1%) | $2.04B(+2.3%) |
| Dec 2014 | $2.00B(+6.9%) | $515.40M(+6.2%) | $1.99B(+7.3%) |
| Sep 2014 | - | $485.50M(+1.9%) | $1.86B(+1.5%) |
| Jun 2014 | - | $476.30M(-7.9%) | $1.83B(-4.7%) |
| Mar 2014 | - | $517.30M(+36.1%) | $1.92B(+2.9%) |
| Dec 2013 | $1.87B | $380.00M(-17.1%) | $1.87B(-2.8%) |
| Sep 2013 | - | $458.50M(-19.0%) | $1.92B(+0.1%) |
| Jun 2013 | - | $566.20M(+22.3%) | $1.92B(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $462.80M(+6.5%) | $1.89B(-2.9%) |
| Dec 2012 | $1.94B(-14.8%) | $434.70M(-4.7%) | $1.94B(-1.1%) |
| Sep 2012 | - | $456.30M(-14.5%) | $1.96B(-8.4%) |
| Jun 2012 | - | $533.80M(+3.0%) | $2.15B(-3.0%) |
| Mar 2012 | - | $518.40M(+13.7%) | $2.21B(-3.1%) |
| Dec 2011 | $2.28B(+10.3%) | $456.10M(-28.5%) | $2.28B(-2.5%) |
| Sep 2011 | - | $637.50M(+6.4%) | $2.34B(+5.8%) |
| Jun 2011 | - | $599.20M(+1.9%) | $2.21B(+0.9%) |
| Mar 2011 | - | $588.20M(+14.4%) | $2.19B(+5.0%) |
| Dec 2010 | $2.07B(+12.9%) | $514.10M(+1.1%) | $2.09B(+2.1%) |
| Sep 2010 | - | $508.40M(-12.3%) | $2.04B(+2.2%) |
| Jun 2010 | - | $580.00M(+20.0%) | $2.00B(+6.3%) |
| Mar 2010 | - | $483.40M(+2.8%) | $1.88B(+1.4%) |
| Dec 2009 | $1.83B(+1.1%) | $470.40M(+1.1%) | $1.85B(-1.4%) |
| Sep 2009 | - | $465.10M(+0.9%) | $1.88B(-2.3%) |
| Jun 2009 | - | $461.10M(+0.6%) | $1.93B(+4.5%) |
| Mar 2009 | - | $458.20M(-7.9%) | $1.84B(-0.3%) |
| Dec 2008 | $1.81B(+51.3%) | $497.68M(-2.2%) | $1.85B(+6.6%) |
| Sep 2008 | - | $508.87M(+34.3%) | $1.73B(+8.0%) |
| Jun 2008 | - | $378.77M(-18.2%) | $1.61B(+11.2%) |
| Mar 2008 | - | $462.97M(+20.8%) | $1.44B(+20.1%) |
| Dec 2007 | $1.20B(+98.5%) | $383.22M(+0.6%) | $1.20B(+23.5%) |
| Sep 2007 | - | $380.86M(+75.9%) | $973.08M(+29.9%) |
| Jun 2007 | - | $216.49M(-2.0%) | $749.17M(+7.9%) |
| Mar 2007 | - | $220.98M(+42.8%) | $694.35M(+15.3%) |
| Dec 2006 | $602.93M(+23.9%) | $154.75M(-1.4%) | $602.33M(+7.4%) |
| Sep 2006 | - | $156.95M(-2.9%) | $560.88M(+7.0%) |
| Jun 2006 | - | $161.67M(+25.4%) | $524.01M(+5.6%) |
| Mar 2006 | - | $128.95M(+13.8%) | $496.13M(+2.9%) |
| Dec 2005 | $486.46M(+15.4%) | $113.30M(-5.7%) | $482.06M(+1.1%) |
| Sep 2005 | - | $120.09M(-10.2%) | $476.96M(+0.5%) |
| Jun 2005 | - | $133.79M(+16.5%) | $474.73M(+5.4%) |
| Mar 2005 | - | $114.88M(+6.2%) | $450.37M(+5.8%) |
| Dec 2004 | $421.43M(+57.3%) | $108.20M(-8.2%) | $425.74M(+11.2%) |
| Sep 2004 | - | $117.86M(+7.7%) | $382.81M(+14.8%) |
| Jun 2004 | - | $109.43M(+21.3%) | $333.41M(-2.2%) |
| Mar 2004 | - | $90.24M(+38.2%) | $340.91M(+10.8%) |
| Dec 2003 | $267.88M(+32.1%) | $65.28M(-4.7%) | $307.63M(-0.2%) |
| Sep 2003 | - | $68.46M(-41.4%) | $308.34M(+8.4%) |
| Jun 2003 | - | $116.93M(+105.3%) | $284.49M(+32.0%) |
| Mar 2003 | - | $56.97M(-13.7%) | $215.56M(+7.3%) |
| Dec 2002 | $202.74M(+17.3%) | $65.99M(+47.9%) | $200.97M(+17.4%) |
| Sep 2002 | - | $44.61M(-7.1%) | $171.12M(-0.6%) |
| Jun 2002 | - | $48.00M(+13.3%) | $172.22M(+9.4%) |
| Mar 2002 | - | $42.38M(+17.3%) | $157.46M(+36.8%) |
| Dec 2001 | $172.88M(+580.5%) | $36.13M(-21.0%) | $115.08M(+45.8%) |
| Sep 2001 | - | $45.72M(+37.5%) | $78.96M(+137.5%) |
| Jun 2001 | - | $33.24M | $33.24M |
| Dec 2000 | $25.41M(-14.7%) | - | - |
| Dec 1999 | $29.79M | - | - |
FAQ
- What is CME Group Inc. annual EBITDA?
- What is the all time high annual EBITDA for CME Group Inc.?
- What is CME Group Inc. annual EBITDA year-on-year change?
- What is CME Group Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for CME Group Inc.?
- What is CME Group Inc. quarterly EBITDA year-on-year change?
- What is CME Group Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for CME Group Inc.?
- What is CME Group Inc. TTM EBITDA year-on-year change?
What is CME Group Inc. annual EBITDA?
The current annual EBITDA of CME is $4.27B
What is the all time high annual EBITDA for CME Group Inc.?
CME Group Inc. all-time high annual EBITDA is $4.27B
What is CME Group Inc. annual EBITDA year-on-year change?
Over the past year, CME annual EBITDA has changed by +$480.00M (+12.67%)
What is CME Group Inc. quarterly EBITDA?
The current quarterly EBITDA of CME is $1.21B
What is the all time high quarterly EBITDA for CME Group Inc.?
CME Group Inc. all-time high quarterly EBITDA is $1.21B
What is CME Group Inc. quarterly EBITDA year-on-year change?
Over the past year, CME quarterly EBITDA has changed by +$127.90M (+11.79%)
What is CME Group Inc. TTM EBITDA?
The current TTM EBITDA of CME is $4.54B
What is the all time high TTM EBITDA for CME Group Inc.?
CME Group Inc. all-time high TTM EBITDA is $4.54B
What is CME Group Inc. TTM EBITDA year-on-year change?
Over the past year, CME TTM EBITDA has changed by +$554.10M (+13.90%)